LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Barasertib | 10 | uM | LJP5 | 72 | hr | 1694 | 2049 | 11103 | 0.1846 | 0.0726 |
MCF 10A | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 10963 | 11103 | 0.9874 | 0.9906 |
MCF 10A | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10857 | 11103 | 0.9778 | 0.9834 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10972 | 11103 | 0.9882 | 0.9913 |
MCF 10A | Vemurafenib | 1.11 | uM | LJP5 | 72 | hr | 1694 | 10870 | 11103 | 0.9790 | 0.9844 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 9108 | 11103 | 0.8204 | 0.8590 |
MCF 10A | Vemurafenib | 10 | uM | LJP5 | 72 | hr | 1694 | 5157 | 11103 | 0.4646 | 0.5069 |
MCF 10A | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11228 | 11103 | 1.0112 | 1.0082 |
MCF 10A | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 1694 | 11143 | 11103 | 1.0035 | 1.0025 |
MCF 10A | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 1694 | 11178 | 11103 | 1.0067 | 1.0049 |
MCF 10A | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 1694 | 11564 | 11103 | 1.0414 | 1.0300 |
MCF 10A | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 1694 | 11663 | 11103 | 1.0504 | 1.0365 |
MCF 10A | Enzastaurin | 10 | uM | LJP5 | 72 | hr | 1694 | 12028 | 11103 | 1.0833 | 1.0598 |
MCF 10A | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 9116 | 11217 | 0.8127 | 0.8535 |
MCF 10A | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 8038 | 11217 | 0.7167 | 0.7700 |
MCF 10A | Palbociclib | 0.37 | uM | LJP6 | 72 | hr | 1694 | 7285 | 11217 | 0.6495 | 0.7072 |
MCF 10A | Palbociclib | 1.11 | uM | LJP6 | 72 | hr | 1694 | 6292 | 11217 | 0.5610 | 0.6178 |
MCF 10A | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 5616 | 11217 | 0.5007 | 0.5519 |
MCF 10A | Palbociclib | 10 | uM | LJP6 | 72 | hr | 1694 | 4663 | 11217 | 0.4157 | 0.4494 |
MCF 10A | PF562271 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 9484 | 11217 | 0.8455 | 0.8806 |
MCF 10A | PF562271 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 8613 | 11217 | 0.7680 | 0.8154 |
MCF 10A | PF562271 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 6920 | 11217 | 0.6170 | 0.6754 |
MCF 10A | PF562271 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 5198 | 11217 | 0.4635 | 0.5085 |
MCF 10A | PF562271 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 2166 | 11217 | 0.1931 | 0.0942 |
MCF 10A | PF562271 | 10 | uM | LJP6 | 72 | hr | 1694 | 494 | 11217 | 0.0440 | -0.3639 |